Quarterly report (Form 10-Q)
Johnson & Johnson 10-Q for Quarter ended Sep 27, 2026
Filing excerpt
Sales by international companies were $31.9 billion, which represented an increase of 6.2%, including an operational increase of 3.0%, and a positive currency impact of 3.2% as compared to the fiscal nine months sales of 2025.